StomachNeoplasms

Potential non-invasive screening tool for stomach cancer on the cards!  

Stream A systematic approach to therapeutic target selection in oesophago-gastric cancer by BMJ talk medicine from desktop or your mobile device  

Stream Intra-tumoural stroma as a predictor of survival in patients with gastric cancer by BMJ talk medicine from desktop or your mobile device  

Objectives To determine whether searching for Helicobacter pylori and treating with eradication therapy leads to a reduction in incidence of gastric cancer among healthy asymptomatic infected individuals.  

The possibility that peptic ulcer and gastric cancer could be an infectious disease would have been dismissed as ridiculous 30 years ago. We now realise that Helicobacter pylori infection is the major cause of both. As H pylori infection has been implicated in various upper gastrointestinal diseases, testing for the bacterium non-invasively and treating infected individuals (“test and treat”) has become widespread. The key question is in which group of patients is this approach appropriate?  

The possibility that peptic ulcer and gastric cancer could be an infectious disease would have been dismissed as ridiculous 30 years ago. We now realise that Helicobacter pylori infection is the major cause of both. As H pylori infection has been implicated in various upper gastrointestinal diseases, testing for the bacterium non-invasively and treating infected individuals (“test and treat”) has become widespread. The key question is in which group of patients is this approach appropriate?  

Stream A systematic approach to therapeutic target selection in oesophago-gastric cancer by BMJ talk medicine from desktop or your mobile device  

Stream Intra-tumoural stroma as a predictor of survival in patients with gastric cancer by BMJ talk medicine from desktop or your mobile device  

Nanoarray analysis, a technology that senses tiny changes in volatile organic compounds in exhaled breath, could be a useful non-invasive screening tool for stomach cancer, research in the journal Gut has concluded.1  

Nanoarray analysis, a technology that senses tiny changes in volatile organic compounds in exhaled breath, could be a useful non-invasive screening tool for stomach cancer, research in the journal Gut has concluded.1  

Nanoarray analysis, a technology that senses tiny changes in volatile organic compounds in exhaled breath, could be a useful non-invasive screening tool for stomach cancer, research in the journal Gut has concluded.1  

The majority of gastric cancers harbor genomic alterations (GAs) associated with potential benefit from targeted therapies, according to a new study published in The Oncologist.  

Researchers have developed a test that they say could accurately diagnose stomach cancer or predict risk for the disease by analyzing an individual's exhaled breath.  

Stream A systematic approach to therapeutic target selection in oesophago-gastric cancer by BMJ talk medicine from desktop or your mobile device  

Stream Intra-tumoural stroma as a predictor of survival in patients with gastric cancer by BMJ talk medicine from desktop or your mobile device  

Gastrectomy remains the primary therapeutic method for resectable gastric cancer. It is believed that abdominal drains can help in the earlier detection and drainage of anastomotic fistulas and the prevention of intra-abdominal abscesses. There is no consensus on the routine placement of abdominal drainage after gastrectomy for gastric cancer.  

Eradicating Helicobacter pylori infection in otherwise healthy and asymptomatic people reduces the incidence of gastric cancer, a systematic review and meta-analysis published by the Cochrane Library has concluded.1  

Whether testing healthy people for Helicobacter pylori and treating those infected routinely with a course of antibiotics decreases the number of new cases of gastric cancer.